61
Growth Score in past quarter
pts
Heat Score 61 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2278577
Vivomicx is a company active in deep analysis of subgroups of cells within tissue.
- Siert Bruins: CEO & Co-Founder
- Jan W. Zuidema: CBO & founder
About the Company
Vivomicx it is crucial to match the pharmacological effects of a new drug to the target cells in a tissue, however, this is seldom accomplished at a cellular level. Vivomicx can tell you what the effects of a drug are on the gene expression profiles of subsets of cells in the organ where the disease is located. These subset cells may either be the
target cells for desired effects of the drug or the non target cells to study bystander effects of undesired toxicity, thus better supporting your compound's decisions. They identify real biomarkers for drug efficacy to speed up your development process. Using this, you can relate true molecular effects to disease activity and the value of your biomarkers.